SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/B5F806703A1F5F898497B5DE370CC7767A1212225AA9E42DFB9CF2BDF6C8E1C57CDEA17C69D4219575E6151A0218204A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/B5F806703A1F5F898497B5DE370CC7767A1212225AA9E42DFB9CF2BDF6C8E1C57CDEA17C69D4219575E6151A0218204A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/B5F806703A1F5F898497B5DE370CC7767A1212225AA9E42DFB9CF2BDF6C8E1C57CDEA17C69D4219575E6151A0218204A
http://www.w3.org/2000/01/rdf-schema#comment
"Data show that cisplatin response was enhanced in human lung cancer cells when Nit1 was knocked down and mice Nit1-/-:KrasG12D/+ tumors showed increased sensitivity to cisplatin in vivo."
xsd:string
http://purl.uniprot.org/uniprot/#_66FD37D5E801D446F19A402BF44AD8731EA50788DE131357387C021A610CC91BF1224B00DB359CAC04F1BE7CF0B969AD
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/B5F806703A1F5F898497B5DE370CC7767A1212225AA9E42DFB9CF2BDF6C8E1C57CDEA17C69D4219575E6151A0218204A
http://purl.uniprot.org/uniprot/Q86X76
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B5F806703A1F5F898497B5DE370CC7767A1212225AA9E42DFB9CF2BDF6C8E1C57CDEA17C69D4219575E6151A0218204A
http://purl.uniprot.org/uniprot/#_Q86X76-mappedCitation-26967383
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B5F806703A1F5F898497B5DE370CC7767A1212225AA9E42DFB9CF2BDF6C8E1C57CDEA17C69D4219575E6151A0218204A